HEADER VIRAL PROTEIN 30-JAN-23 8I71 TITLE HEPATITIS B VIRUS CORE PROTEIN Y132A MUTANT IN COMPLEX WITH TITLE 2 LINVENCORVIR (RG7907), A HEPATITIS B VIRUS (HBV) CORE PROTEIN TITLE 3 ALLOSTERIC MODULATOR (CPAM) COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAPSID PROTEIN; COMPND 3 CHAIN: A, B, C, D, E, F; COMPND 4 SYNONYM: CORE ANTIGEN,CORE PROTEIN,HBCAG,P21.5; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HEPATITIS B VIRUS SUBTYPE ADYW; SOURCE 3 ORGANISM_TAXID: 10419; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CAPSID ASSEMBLY INHIBITOR, ANTIVIRAL PROTEIN, VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR Z.ZHOU,Z.H.XU REVDAT 3 23-OCT-24 8I71 1 REMARK REVDAT 2 05-APR-23 8I71 1 JRNL REVDAT 1 22-MAR-23 8I71 0 JRNL AUTH W.ZHANG,L.GUO,H.LIU,G.WU,H.SHI,M.ZHOU,Z.ZHANG,B.KOU,T.HU, JRNL AUTH 2 Z.ZHOU,Z.XU,X.ZHOU,Y.ZHOU,X.TIAN,G.YANG,J.A.T.YOUNG,H.QIU, JRNL AUTH 3 G.OTTAVIANI,J.XIE,A.V.MAYWEG,H.C.SHEN,W.ZHU JRNL TITL DISCOVERY OF LINVENCORVIR (RG7907), A HEPATITIS B VIRUS CORE JRNL TITL 2 PROTEIN ALLOSTERIC MODULATOR, FOR THE TREATMENT OF CHRONIC JRNL TITL 3 HBV INFECTION. JRNL REF J.MED.CHEM. V. 66 4253 2023 JRNL REFN ISSN 0022-2623 JRNL PMID 36896968 JRNL DOI 10.1021/ACS.JMEDCHEM.3C00173 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.51 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.960 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.4 REMARK 3 NUMBER OF REFLECTIONS : 159928 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.156 REMARK 3 R VALUE (WORKING SET) : 0.155 REMARK 3 FREE R VALUE : 0.193 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.470 REMARK 3 FREE R VALUE TEST SET COUNT : 3952 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 33.5130 - 4.8538 0.95 5564 140 0.1565 0.1828 REMARK 3 2 4.8538 - 3.8544 0.99 5803 146 0.1210 0.1595 REMARK 3 3 3.8544 - 3.3677 0.97 5654 139 0.1328 0.1773 REMARK 3 4 3.3677 - 3.0600 0.96 5604 139 0.1446 0.1801 REMARK 3 5 3.0600 - 2.8408 0.96 5625 140 0.1502 0.1834 REMARK 3 6 2.8408 - 2.6734 0.97 5663 151 0.1530 0.2003 REMARK 3 7 2.6734 - 2.5396 0.97 5688 132 0.1524 0.1950 REMARK 3 8 2.5396 - 2.4291 0.97 5654 147 0.1466 0.1989 REMARK 3 9 2.4291 - 2.3356 0.97 5626 149 0.1321 0.1801 REMARK 3 10 2.3356 - 2.2550 0.97 5635 140 0.1300 0.1563 REMARK 3 11 2.2550 - 2.1845 0.96 5670 140 0.1407 0.1923 REMARK 3 12 2.1845 - 2.1221 0.96 5650 136 0.1365 0.2048 REMARK 3 13 2.1221 - 2.0662 0.97 5598 141 0.1506 0.1976 REMARK 3 14 2.0662 - 2.0158 0.96 5633 131 0.1529 0.1903 REMARK 3 15 2.0158 - 1.9700 0.96 5572 166 0.1627 0.1992 REMARK 3 16 1.9700 - 1.9281 0.96 5594 142 0.1672 0.1832 REMARK 3 17 1.9281 - 1.8895 0.96 5615 137 0.1769 0.2214 REMARK 3 18 1.8895 - 1.8538 0.95 5592 149 0.1802 0.2050 REMARK 3 19 1.8538 - 1.8207 0.95 5530 135 0.1973 0.2359 REMARK 3 20 1.8207 - 1.7899 0.96 5561 152 0.2119 0.2301 REMARK 3 21 1.7899 - 1.7610 0.95 5565 124 0.2225 0.2473 REMARK 3 22 1.7610 - 1.7339 0.95 5575 135 0.2315 0.2761 REMARK 3 23 1.7339 - 1.7084 0.95 5598 163 0.2529 0.2554 REMARK 3 24 1.7084 - 1.6844 0.94 5426 144 0.2690 0.2951 REMARK 3 25 1.6844 - 1.6616 0.94 5431 136 0.2810 0.3026 REMARK 3 26 1.6616 - 1.6400 0.92 5417 127 0.3033 0.2986 REMARK 3 27 1.6400 - 1.6195 0.91 5338 143 0.3114 0.3207 REMARK 3 28 1.6195 - 1.6000 0.88 5095 128 0.3248 0.3209 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.150 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.570 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.011 7860 REMARK 3 ANGLE : 0.966 10802 REMARK 3 CHIRALITY : 0.053 1189 REMARK 3 PLANARITY : 0.007 1359 REMARK 3 DIHEDRAL : 17.306 4523 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8I71 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 10-FEB-23. REMARK 100 THE DEPOSITION ID IS D_1300035039. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-MAR-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9793 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 650539 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 23.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.63 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.81100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM CITRATE, 21%(VOL/VOL) REMARK 280 ISOPROPANOL, 1%(W/V) PEG 10000, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 143 REMARK 465 PRO A 144 REMARK 465 GLU A 145 REMARK 465 THR A 146 REMARK 465 THR A 147 REMARK 465 VAL A 148 REMARK 465 LEU C 143 REMARK 465 PRO C 144 REMARK 465 GLU C 145 REMARK 465 THR C 146 REMARK 465 THR C 147 REMARK 465 VAL C 148 REMARK 465 VAL C 149 REMARK 465 PRO E 144 REMARK 465 GLU E 145 REMARK 465 THR E 146 REMARK 465 THR E 147 REMARK 465 VAL E 148 REMARK 465 LEU F 143 REMARK 465 PRO F 144 REMARK 465 GLU F 145 REMARK 465 THR F 146 REMARK 465 THR F 147 REMARK 465 VAL F 148 REMARK 465 VAL F 149 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH C 308 O HOH C 407 2.15 REMARK 500 O HOH C 406 O HOH C 407 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 48 -59.73 71.97 REMARK 500 ASP A 78 123.23 79.24 REMARK 500 ASN A 92 -84.92 -107.94 REMARK 500 CYS B 48 -60.35 73.03 REMARK 500 CYS C 48 -60.30 72.60 REMARK 500 ASN C 92 -78.62 -106.89 REMARK 500 CYS D 48 -60.32 70.73 REMARK 500 ASN D 92 -69.29 -105.81 REMARK 500 CYS E 48 -61.81 72.33 REMARK 500 ASP E 78 -83.09 -112.52 REMARK 500 SER E 81 -6.64 -55.56 REMARK 500 ARG E 82 13.66 51.04 REMARK 500 ASN E 92 -64.56 -101.44 REMARK 500 CYS F 48 -61.13 66.17 REMARK 500 CYS F 48 -61.13 71.92 REMARK 500 ASN F 92 -74.30 -106.76 REMARK 500 PHE F 154 -175.59 -69.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH D 416 DISTANCE = 6.57 ANGSTROMS REMARK 525 HOH F 411 DISTANCE = 6.97 ANGSTROMS DBREF 8I71 A 1 149 UNP P03147 CAPSD_HBVD1 1 149 DBREF 8I71 B 1 149 UNP P03147 CAPSD_HBVD1 1 149 DBREF 8I71 C 1 149 UNP P03147 CAPSD_HBVD1 1 149 DBREF 8I71 D 1 149 UNP P03147 CAPSD_HBVD1 1 149 DBREF 8I71 E 1 149 UNP P03147 CAPSD_HBVD1 1 149 DBREF 8I71 F 1 149 UNP P03147 CAPSD_HBVD1 1 149 SEQADV 8I71 ALA A 132 UNP P03147 TYR 132 ENGINEERED MUTATION SEQADV 8I71 GLU A 150 UNP P03147 EXPRESSION TAG SEQADV 8I71 ASN A 151 UNP P03147 EXPRESSION TAG SEQADV 8I71 LEU A 152 UNP P03147 EXPRESSION TAG SEQADV 8I71 TYR A 153 UNP P03147 EXPRESSION TAG SEQADV 8I71 PHE A 154 UNP P03147 EXPRESSION TAG SEQADV 8I71 GLN A 155 UNP P03147 EXPRESSION TAG SEQADV 8I71 ALA B 132 UNP P03147 TYR 132 ENGINEERED MUTATION SEQADV 8I71 GLU B 150 UNP P03147 EXPRESSION TAG SEQADV 8I71 ASN B 151 UNP P03147 EXPRESSION TAG SEQADV 8I71 LEU B 152 UNP P03147 EXPRESSION TAG SEQADV 8I71 TYR B 153 UNP P03147 EXPRESSION TAG SEQADV 8I71 PHE B 154 UNP P03147 EXPRESSION TAG SEQADV 8I71 GLN B 155 UNP P03147 EXPRESSION TAG SEQADV 8I71 ALA C 132 UNP P03147 TYR 132 ENGINEERED MUTATION SEQADV 8I71 GLU C 150 UNP P03147 EXPRESSION TAG SEQADV 8I71 ASN C 151 UNP P03147 EXPRESSION TAG SEQADV 8I71 LEU C 152 UNP P03147 EXPRESSION TAG SEQADV 8I71 TYR C 153 UNP P03147 EXPRESSION TAG SEQADV 8I71 PHE C 154 UNP P03147 EXPRESSION TAG SEQADV 8I71 GLN C 155 UNP P03147 EXPRESSION TAG SEQADV 8I71 ALA D 132 UNP P03147 TYR 132 ENGINEERED MUTATION SEQADV 8I71 GLU D 150 UNP P03147 EXPRESSION TAG SEQADV 8I71 ASN D 151 UNP P03147 EXPRESSION TAG SEQADV 8I71 LEU D 152 UNP P03147 EXPRESSION TAG SEQADV 8I71 TYR D 153 UNP P03147 EXPRESSION TAG SEQADV 8I71 PHE D 154 UNP P03147 EXPRESSION TAG SEQADV 8I71 GLN D 155 UNP P03147 EXPRESSION TAG SEQADV 8I71 ALA E 132 UNP P03147 TYR 132 ENGINEERED MUTATION SEQADV 8I71 GLU E 150 UNP P03147 EXPRESSION TAG SEQADV 8I71 ASN E 151 UNP P03147 EXPRESSION TAG SEQADV 8I71 LEU E 152 UNP P03147 EXPRESSION TAG SEQADV 8I71 TYR E 153 UNP P03147 EXPRESSION TAG SEQADV 8I71 PHE E 154 UNP P03147 EXPRESSION TAG SEQADV 8I71 GLN E 155 UNP P03147 EXPRESSION TAG SEQADV 8I71 ALA F 132 UNP P03147 TYR 132 ENGINEERED MUTATION SEQADV 8I71 GLU F 150 UNP P03147 EXPRESSION TAG SEQADV 8I71 ASN F 151 UNP P03147 EXPRESSION TAG SEQADV 8I71 LEU F 152 UNP P03147 EXPRESSION TAG SEQADV 8I71 TYR F 153 UNP P03147 EXPRESSION TAG SEQADV 8I71 PHE F 154 UNP P03147 EXPRESSION TAG SEQADV 8I71 GLN F 155 UNP P03147 EXPRESSION TAG SEQRES 1 A 155 MET ASP ILE ASP PRO TYR LYS GLU PHE GLY ALA THR VAL SEQRES 2 A 155 GLU LEU LEU SER PHE LEU PRO SER ASP PHE PHE PRO SER SEQRES 3 A 155 VAL ARG ASP LEU LEU ASP THR ALA ALA ALA LEU TYR ARG SEQRES 4 A 155 ASP ALA LEU GLU SER PRO GLU HIS CYS SER PRO HIS HIS SEQRES 5 A 155 THR ALA LEU ARG GLN ALA ILE LEU CYS TRP GLY ASP LEU SEQRES 6 A 155 MET THR LEU ALA THR TRP VAL GLY THR ASN LEU GLU ASP SEQRES 7 A 155 PRO ALA SER ARG ASP LEU VAL VAL SER TYR VAL ASN THR SEQRES 8 A 155 ASN VAL GLY LEU LYS PHE ARG GLN LEU LEU TRP PHE HIS SEQRES 9 A 155 ILE SER CYS LEU THR PHE GLY ARG GLU THR VAL LEU GLU SEQRES 10 A 155 TYR LEU VAL SER PHE GLY VAL TRP ILE ARG THR PRO PRO SEQRES 11 A 155 ALA ALA ARG PRO PRO ASN ALA PRO ILE LEU SER THR LEU SEQRES 12 A 155 PRO GLU THR THR VAL VAL GLU ASN LEU TYR PHE GLN SEQRES 1 B 155 MET ASP ILE ASP PRO TYR LYS GLU PHE GLY ALA THR VAL SEQRES 2 B 155 GLU LEU LEU SER PHE LEU PRO SER ASP PHE PHE PRO SER SEQRES 3 B 155 VAL ARG ASP LEU LEU ASP THR ALA ALA ALA LEU TYR ARG SEQRES 4 B 155 ASP ALA LEU GLU SER PRO GLU HIS CYS SER PRO HIS HIS SEQRES 5 B 155 THR ALA LEU ARG GLN ALA ILE LEU CYS TRP GLY ASP LEU SEQRES 6 B 155 MET THR LEU ALA THR TRP VAL GLY THR ASN LEU GLU ASP SEQRES 7 B 155 PRO ALA SER ARG ASP LEU VAL VAL SER TYR VAL ASN THR SEQRES 8 B 155 ASN VAL GLY LEU LYS PHE ARG GLN LEU LEU TRP PHE HIS SEQRES 9 B 155 ILE SER CYS LEU THR PHE GLY ARG GLU THR VAL LEU GLU SEQRES 10 B 155 TYR LEU VAL SER PHE GLY VAL TRP ILE ARG THR PRO PRO SEQRES 11 B 155 ALA ALA ARG PRO PRO ASN ALA PRO ILE LEU SER THR LEU SEQRES 12 B 155 PRO GLU THR THR VAL VAL GLU ASN LEU TYR PHE GLN SEQRES 1 C 155 MET ASP ILE ASP PRO TYR LYS GLU PHE GLY ALA THR VAL SEQRES 2 C 155 GLU LEU LEU SER PHE LEU PRO SER ASP PHE PHE PRO SER SEQRES 3 C 155 VAL ARG ASP LEU LEU ASP THR ALA ALA ALA LEU TYR ARG SEQRES 4 C 155 ASP ALA LEU GLU SER PRO GLU HIS CYS SER PRO HIS HIS SEQRES 5 C 155 THR ALA LEU ARG GLN ALA ILE LEU CYS TRP GLY ASP LEU SEQRES 6 C 155 MET THR LEU ALA THR TRP VAL GLY THR ASN LEU GLU ASP SEQRES 7 C 155 PRO ALA SER ARG ASP LEU VAL VAL SER TYR VAL ASN THR SEQRES 8 C 155 ASN VAL GLY LEU LYS PHE ARG GLN LEU LEU TRP PHE HIS SEQRES 9 C 155 ILE SER CYS LEU THR PHE GLY ARG GLU THR VAL LEU GLU SEQRES 10 C 155 TYR LEU VAL SER PHE GLY VAL TRP ILE ARG THR PRO PRO SEQRES 11 C 155 ALA ALA ARG PRO PRO ASN ALA PRO ILE LEU SER THR LEU SEQRES 12 C 155 PRO GLU THR THR VAL VAL GLU ASN LEU TYR PHE GLN SEQRES 1 D 155 MET ASP ILE ASP PRO TYR LYS GLU PHE GLY ALA THR VAL SEQRES 2 D 155 GLU LEU LEU SER PHE LEU PRO SER ASP PHE PHE PRO SER SEQRES 3 D 155 VAL ARG ASP LEU LEU ASP THR ALA ALA ALA LEU TYR ARG SEQRES 4 D 155 ASP ALA LEU GLU SER PRO GLU HIS CYS SER PRO HIS HIS SEQRES 5 D 155 THR ALA LEU ARG GLN ALA ILE LEU CYS TRP GLY ASP LEU SEQRES 6 D 155 MET THR LEU ALA THR TRP VAL GLY THR ASN LEU GLU ASP SEQRES 7 D 155 PRO ALA SER ARG ASP LEU VAL VAL SER TYR VAL ASN THR SEQRES 8 D 155 ASN VAL GLY LEU LYS PHE ARG GLN LEU LEU TRP PHE HIS SEQRES 9 D 155 ILE SER CYS LEU THR PHE GLY ARG GLU THR VAL LEU GLU SEQRES 10 D 155 TYR LEU VAL SER PHE GLY VAL TRP ILE ARG THR PRO PRO SEQRES 11 D 155 ALA ALA ARG PRO PRO ASN ALA PRO ILE LEU SER THR LEU SEQRES 12 D 155 PRO GLU THR THR VAL VAL GLU ASN LEU TYR PHE GLN SEQRES 1 E 155 MET ASP ILE ASP PRO TYR LYS GLU PHE GLY ALA THR VAL SEQRES 2 E 155 GLU LEU LEU SER PHE LEU PRO SER ASP PHE PHE PRO SER SEQRES 3 E 155 VAL ARG ASP LEU LEU ASP THR ALA ALA ALA LEU TYR ARG SEQRES 4 E 155 ASP ALA LEU GLU SER PRO GLU HIS CYS SER PRO HIS HIS SEQRES 5 E 155 THR ALA LEU ARG GLN ALA ILE LEU CYS TRP GLY ASP LEU SEQRES 6 E 155 MET THR LEU ALA THR TRP VAL GLY THR ASN LEU GLU ASP SEQRES 7 E 155 PRO ALA SER ARG ASP LEU VAL VAL SER TYR VAL ASN THR SEQRES 8 E 155 ASN VAL GLY LEU LYS PHE ARG GLN LEU LEU TRP PHE HIS SEQRES 9 E 155 ILE SER CYS LEU THR PHE GLY ARG GLU THR VAL LEU GLU SEQRES 10 E 155 TYR LEU VAL SER PHE GLY VAL TRP ILE ARG THR PRO PRO SEQRES 11 E 155 ALA ALA ARG PRO PRO ASN ALA PRO ILE LEU SER THR LEU SEQRES 12 E 155 PRO GLU THR THR VAL VAL GLU ASN LEU TYR PHE GLN SEQRES 1 F 155 MET ASP ILE ASP PRO TYR LYS GLU PHE GLY ALA THR VAL SEQRES 2 F 155 GLU LEU LEU SER PHE LEU PRO SER ASP PHE PHE PRO SER SEQRES 3 F 155 VAL ARG ASP LEU LEU ASP THR ALA ALA ALA LEU TYR ARG SEQRES 4 F 155 ASP ALA LEU GLU SER PRO GLU HIS CYS SER PRO HIS HIS SEQRES 5 F 155 THR ALA LEU ARG GLN ALA ILE LEU CYS TRP GLY ASP LEU SEQRES 6 F 155 MET THR LEU ALA THR TRP VAL GLY THR ASN LEU GLU ASP SEQRES 7 F 155 PRO ALA SER ARG ASP LEU VAL VAL SER TYR VAL ASN THR SEQRES 8 F 155 ASN VAL GLY LEU LYS PHE ARG GLN LEU LEU TRP PHE HIS SEQRES 9 F 155 ILE SER CYS LEU THR PHE GLY ARG GLU THR VAL LEU GLU SEQRES 10 F 155 TYR LEU VAL SER PHE GLY VAL TRP ILE ARG THR PRO PRO SEQRES 11 F 155 ALA ALA ARG PRO PRO ASN ALA PRO ILE LEU SER THR LEU SEQRES 12 F 155 PRO GLU THR THR VAL VAL GLU ASN LEU TYR PHE GLN HET CL A 201 1 HET IPA A 202 4 HET IPA A 203 4 HET GOL A 204 6 HET GOL A 205 6 HET OTI A 206 42 HET DMS A 207 4 HET IPA B 201 4 HET GOL B 202 6 HET GOL B 203 6 HET OTI B 204 42 HET CL C 201 1 HET IPA C 202 4 HET IPA C 203 4 HET IPA C 204 4 HET OTI C 205 42 HET CL D 201 1 HET CL D 202 1 HET IPA D 203 4 HET OTI D 204 42 HET CL E 201 1 HET OTI E 202 42 HET IPA F 201 4 HET IPA F 202 4 HET OTI F 203 42 HETNAM CL CHLORIDE ION HETNAM IPA ISOPROPYL ALCOHOL HETNAM GOL GLYCEROL HETNAM OTI 3-[(8~{A}~{S})-7-[[5-ETHOXYCARBONYL-4-(3-FLUORANYL-2- HETNAM 2 OTI METHYL-PHENYL)-2-(1,3-THIAZOL-2-YL)-1,4- HETNAM 3 OTI DIHYDROPYRIMIDIN-6-YL]METHYL]-3-OXIDANYLIDENE-5,6,8, HETNAM 4 OTI 8~{A}-TETRAHYDRO-1~{H}-IMIDAZO[1,5-A]PYRAZIN-2-YL]-2, HETNAM 5 OTI 2-DIMETHYL-PROPANOIC ACID HETNAM DMS DIMETHYL SULFOXIDE HETSYN IPA 2-PROPANOL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN OTI LINVENCORVIR FORMUL 7 CL 5(CL 1-) FORMUL 8 IPA 9(C3 H8 O) FORMUL 10 GOL 4(C3 H8 O3) FORMUL 12 OTI 6(C29 H35 F N6 O5 S) FORMUL 13 DMS C2 H6 O S FORMUL 32 HOH *703(H2 O) HELIX 1 AA1 TYR A 6 GLY A 10 5 5 HELIX 2 AA2 THR A 12 SER A 17 1 6 HELIX 3 AA3 PHE A 18 LEU A 19 5 2 HELIX 4 AA4 PRO A 20 PHE A 24 5 5 HELIX 5 AA5 SER A 26 GLU A 43 1 18 HELIX 6 AA6 SER A 49 ASN A 75 1 27 HELIX 7 AA7 ASP A 78 ASN A 92 1 15 HELIX 8 AA8 ASN A 92 GLY A 111 1 20 HELIX 9 AA9 GLY A 111 THR A 128 1 18 HELIX 10 AB1 PRO A 129 ARG A 133 5 5 HELIX 11 AB2 GLU A 150 GLN A 155 5 6 HELIX 12 AB3 TYR B 6 GLY B 10 5 5 HELIX 13 AB4 THR B 12 SER B 17 1 6 HELIX 14 AB5 PHE B 18 LEU B 19 5 2 HELIX 15 AB6 PRO B 20 PHE B 24 5 5 HELIX 16 AB7 SER B 26 GLU B 43 1 18 HELIX 17 AB8 SER B 49 ASN B 75 1 27 HELIX 18 AB9 ASP B 78 ARG B 82 5 5 HELIX 19 AC1 ASP B 83 GLY B 111 1 29 HELIX 20 AC2 GLY B 111 THR B 128 1 18 HELIX 21 AC3 PRO B 129 ARG B 133 5 5 HELIX 22 AC4 THR B 147 PHE B 154 1 8 HELIX 23 AC5 TYR C 6 GLY C 10 5 5 HELIX 24 AC6 THR C 12 SER C 17 1 6 HELIX 25 AC7 PHE C 18 LEU C 19 5 2 HELIX 26 AC8 PRO C 20 PHE C 24 5 5 HELIX 27 AC9 SER C 26 SER C 44 1 19 HELIX 28 AD1 SER C 49 ASN C 75 1 27 HELIX 29 AD2 ASP C 78 ASN C 92 1 15 HELIX 30 AD3 ASN C 92 GLY C 111 1 20 HELIX 31 AD4 GLY C 111 THR C 128 1 18 HELIX 32 AD5 PRO C 129 ARG C 133 5 5 HELIX 33 AD6 TYR D 6 GLY D 10 5 5 HELIX 34 AD7 THR D 12 SER D 17 1 6 HELIX 35 AD8 PHE D 18 LEU D 19 5 2 HELIX 36 AD9 PRO D 20 PHE D 24 5 5 HELIX 37 AE1 SER D 26 GLU D 43 1 18 HELIX 38 AE2 SER D 49 ASN D 75 1 27 HELIX 39 AE3 ASP D 78 ASN D 92 1 15 HELIX 40 AE4 ASN D 92 GLY D 111 1 20 HELIX 41 AE5 GLY D 111 THR D 128 1 18 HELIX 42 AE6 PRO D 129 ARG D 133 5 5 HELIX 43 AE7 THR D 147 PHE D 154 1 8 HELIX 44 AE8 TYR E 6 GLY E 10 5 5 HELIX 45 AE9 THR E 12 SER E 17 1 6 HELIX 46 AF1 PHE E 18 LEU E 19 5 2 HELIX 47 AF2 PRO E 20 PHE E 24 5 5 HELIX 48 AF3 SER E 26 GLU E 43 1 18 HELIX 49 AF4 SER E 49 LEU E 76 1 28 HELIX 50 AF5 ASP E 83 GLY E 111 1 29 HELIX 51 AF6 GLY E 111 THR E 128 1 18 HELIX 52 AF7 PRO E 129 ARG E 133 5 5 HELIX 53 AF8 GLU E 150 GLN E 155 5 6 HELIX 54 AF9 TYR F 6 GLY F 10 5 5 HELIX 55 AG1 THR F 12 SER F 17 1 6 HELIX 56 AG2 PHE F 18 LEU F 19 5 2 HELIX 57 AG3 PRO F 20 PHE F 24 5 5 HELIX 58 AG4 SER F 26 GLU F 43 1 18 HELIX 59 AG5 SER F 49 LEU F 76 1 28 HELIX 60 AG6 ASP F 78 ASN F 92 1 15 HELIX 61 AG7 ASN F 92 GLY F 111 1 20 HELIX 62 AG8 GLY F 111 THR F 128 1 18 HELIX 63 AG9 PRO F 129 ARG F 133 5 5 SSBOND 1 CYS A 61 CYS B 61 1555 1555 2.05 SSBOND 2 CYS C 61 CYS D 61 1555 1555 2.03 SSBOND 3 CYS E 61 CYS F 61 1555 1555 2.04 CRYST1 64.392 67.565 86.246 68.60 69.81 83.87 P 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015530 -0.001668 -0.005473 0.00000 SCALE2 0.000000 0.014886 -0.005590 0.00000 SCALE3 0.000000 0.000000 0.013196 0.00000